About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials | 3,344 Studies Recruiting

Clinical TrialsMelanoma

Melanoma Clinical Trials

Browse 3,344 clinical trials for melanoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1841-1860 of 3,344 trials

CompletedPF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)This protocol allows patients who completed Coley oncology studies using PF-3512676 (CPG 7909) Injection to continue receiving the treatment until disease progression.NCT00043368·Berkely, California and 31 others

Related Searches

skin cancertrials

Data from ClinicalTrials.govTerms

TerminatedCediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung CancerThis phase I trial is studying the side effects and best dose of cediranib maleate when given together with whole brain radiation therapy in treating patients with brain…NCT00937482·Boston, Massachusetts

CompletedTolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-oldSince 2013, therapeutic care of metastatic melanoma (MM) has greatly improved, especially thanks to BRAF and MEK targeted therapies.NCT03155217·Montpellier

UnknownStudy for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.Novel treatment modalities like targeted therapies and Immune checkpoint inhibitors have revolutionised the therapeutic landscape in oncology and hematology, significantly…NCT06321640·Milan

RecruitingIdentification of Metabolic Phenotypes Associated With Melanoma MetastasisThe goal of this study is to observe metabolic features associated with human melanoma tumors.NCT06400550·Dallas, Texas

CompletedA Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma RecurrenceVaccine adjuvants are compounds used to increase specific immune responses to antigens, but have minimal toxicity or lasting immune effects on their own.NCT02334735·New York, New York and 1 other

Not yet recruitingStatins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosisThe goal of this interventional study is to test whether atorvastatin prevents accelerated progression of atherosclerosis in melanoma patients who receive immune checkpoint…NCT06785974·Rotterdam, South Holland

CompletedDiagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II MelanomaRATIONALE: Diagnostic procedures that analyze surgically-removed tumor tissue and lymph node samples may help doctors identify patients with melanoma who are at risk for…NCT00049010·Chicago, Illinois and 26 others

Active not recruitingTesting the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant MelanomaThis phase I/II trial studies the side effects and best dose of dabrafenib, trametinib, and navitoclax and to see how well they work in treating patients with BRAF mutant melanoma…NCT01989585·Phoenix, Arizona and 48 others

CompletedVaccine Therapy and Interleukin-2 in Treating Patients With Metastatic MelanomaRATIONALE: Vaccines may make the body build an immune response that will kill tumor cells. Interleukin-2 may stimulate a person's white blood cells to kill melanoma cells.NCT00054535·Bethesda, Maryland

TerminatedSample Collection From Melanoma PatientsThe goal of this laboratory research study is to collect blood and tumor samples from patients with malignant melanoma.NCT00507325·Houston, Texas

TerminatedPV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous MelanomaThis is an international multicenter, open-label, randomized controlled trial (RCT) of single-agent intralesional PV-10 versus systemic chemotherapy or intralesional oncolytic…NCT02288897·San Diego, California and 22 others

CompletedRetinal Structural and Functional Changes in Patients Treated With BRAF/MEK InhibitorsPatients treated with BRAF/MEK inhibitor combinations for malignant melanoma may develop retinal changes known as MEK inhibitor-associated retinopathy (MEKAR).NCT07431489·Ljubljana

CompletedPhase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous MelanomaThis is a Phase 2, multicenter, randomized, controlled, open-label trial of pimasertib versus dacarbazine aimed to confirm the activity of pimasertib in previously untreated…NCT01693068·Birmingham, Alabama and 100 others

CompletedAI-based Medical Device Validation for Early Melanoma DetectionThe goal of this observational study is to learn if a computer-aided diagnosis (CAD) system can help identify skin cancer (cutaneous melanoma).NCT06221397·Barakaldo, Biscay

CompletedHepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the LiverThe goal of this clinical research is to find the highest tolerable dose of Abraxane (nab-paclitaxel) when given directly to the area where the cancer is located.NCT00833807·Houston, Texas

TerminatedAnti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma PatientsBackground: * Melanoma antigen recognized by T cells (MART-1) is a gene that is present in melanoma cells.NCT00706992·Bethesda, Maryland

CompletedVaccine Therapy in Treating Patients With Stage IV MelanomaRATIONALE: Vaccines may make the body build an immune response to kill tumor cells.NCT00023647·Los Angeles, California

RecruitingPhase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain MetastasesTo learn if giving nivolumab in combination with relatlimab can help to control melanoma that has spread to the brain (melanoma with brain metastases).NCT05704647·Houston, Texas

RecruitingPan-tumor MRD StudyThe purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II, or operable stage…NCT06605404·Birmingham, Alabama and 46 others

PreviousPage 93 of 168Next